Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence

Benzer Materyaller

• Management of portal hypertension
  Yazar:: Samonakis, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
  Yazar:: Burroughs, A K, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• A comparative analysis of carvedilol and propranolol in hepatic venous pressure gradient reduction in patients with cirrhotic portal hypertension
  Yazar:: LI Jing, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)
• Extrahepatic aneurysm of the portal venous system and portal hypertension
  Yazar:: Debernardi-Venon, Wilma, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement
  Yazar:: Mura, Vincenzo La, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)